Insider trading

Period: 120 months Stock: BDX + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

159 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

159 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

159 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

159 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
159 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
159 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

159 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
28 Aug 2023
Fraser Claire Director
Sold at will
$238.85K 848 at 281.66
3.8%
Not planned
11 Aug 2023
Hickey David EVP & President, Life Sciences
Sold on a plan
$826.33K 2,974 at 277.85
41.5%
Planned (10b5-1)
8 Aug 2023
Garrison Michael David EVP & President Medical
Sold on a plan
$360.27K 1,300 at 277.13
20.1%
Planned (10b5-1)
3 Feb 2023
Byrd Richard EVP & President Interventional
Sold, plan not stated
$353.26K 1,421 at 248.60
25.6%
15 Aug 2022
Polen Thomas E Jr Chairman, CEO and President
Sold, plan not stated
$2.52M 9,500 at 265.13
24.8%
15 Aug 2022
Hickey David EVP & President, Life Sciences
Sold, plan not stated
$125.88K 475 at 265.00
12.5%
9 Aug 2022
Khichi Samrat S. EVP and General Counsel
Sold, plan not stated
$2.39M 9,185 at 260.44
60.8%
Sold half or more
9 Aug 2022
Polen Thomas E Jr Executive Vice President
Sold, plan not stated
$429.52K 1,652 at 260.00
5.4%
8 Aug 2022
Khichi Samrat S. EVP and General Counsel
Sold, plan not stated
$1.90M 7,295 at 260.44
55.2%
Sold half or more
7 Jun 2022
Spoerel Thomas J VP Controller & Chief Acct Off
Sold, plan not stated
$115.18K 443 at 260.00
29.5%
6 May 2022
Hickey David EVP & President, Life Sciences
Sold, plan not stated
$121.60K 475 at 256.00
11.1%
25 Feb 2022
Larson Betty D EVP HR & CHRO
Sold, plan not stated 8×
$3.91M 14,374 at 271.90
71.0%
Sold half or more
8 Feb 2022
Fraser Claire Director
Sold, plan not stated
$228.50K 841 at 271.70
3.8%
3 Feb 2022
Conroy Alexandre EVP of Integrated Supply Chain
Sold, plan not stated
$1.73M 6,410 at 270.16
23.2%
16 Dec 2021
Larson Betty D EVP HR & CHRO
Sold, plan not stated 2×
$851.96K 3,341 at 255.00
36.3%
7 Dec 2021
Spoerel Thomas J VP Controller & Chief Acct Off
Sold, plan not stated
$58.25K 233 at 250.00
17.8%
8 Sep 2021
Hickey David EVP & President, Life Sciences
Sold, plan not stated
$130.00K 500 at 260.00
12.2%
8 Sep 2021
RIMEL REBECCA W Director
Sold, plan not stated
$130.00K 500 at 260.00
4.5%
8 Sep 2021
Spoerel Thomas J VP Controller & Chief Acct Off
Sold, plan not stated
$69.42K 267 at 260.00
20.8%
3 Sep 2021
Lim James C Executive Vice President
Sold, plan not stated
$1.79M 6,956 at 257.44
26.0%
3 Sep 2021
RIMEL REBECCA W Director
Sold, plan not stated
$128.55K 500 at 257.10
4.3%
2 Sep 2021
RIMEL REBECCA W Director
Sold, plan not stated
$61.98K 244 at 254.00
2.1%
30 Aug 2021
RIMEL REBECCA W Director
Sold, plan not stated
$52.16K 207 at 252.00
1.7%
18 Aug 2021
Fraser Claire Director
Sold, plan not stated
$97.36K 387 at 251.58
1.9%
17 Aug 2021
RIMEL REBECCA W Director
Sold, plan not stated
$52.16K 207 at 252.00
1.7%
6 Aug 2021
Spoerel Thomas J VP Controller & Chief Acct Off
Sold, plan not stated
$64.45K 266 at 242.30
17.2%
28 May 2021
Lim James C Executive Vice President · indirect
Sold, plan not stated
$828.72K 3,429 at 241.68
81.1%
Sold half or more
27 May 2021
Fraser Claire Director
Sold, plan not stated
$94.13K 390 at 241.36
1.9%
23 Nov 2020
Goette Roland EVP and President, EMEA
Sold, plan not stated
$213.99K 930 at 230.10
10.4%
9 Jul 2020
Kaltenbach Patrick EVP & Pres Life Sciences
Sold, plan not stated
$330.72K 1,272 at 260.00
11.0%
5 Jun 2020
Kaltenbach Patrick EVP & Pres Life Sciences
Sold, plan not stated
$255.12K 1,049 at 243.20
8.3%
2 Jun 2020
Kaltenbach Patrick EVP & Pres Life Sciences
Sold, plan not stated
$54.35K 222 at 244.83
1.5%
8 May 2020
Fraser Claire Director
Sold, plan not stated
$197.81K 771 at 256.56
3.7%
16 Mar 2020
Khichi Samrat S. EVP and General Counsel
Sold, plan not stated
$976.48K 4,349 at 224.53
45.3%
11 Feb 2020
Fraser Claire Director
Sold, plan not stated 2×
$388.07K 1,500 at 258.72
6.7%
4 Feb 2020
Campion Simon D EVP and Segment President
Sold, plan not stated 5×
$2.30M 8,085 at 285.09
42.9%
4 Feb 2020
Mas Ribo Alberto EVP and Pres, Life Sciences
Sold, plan not stated
$407.55K 1,430 at 285.00
14.6%
28 Jan 2020
FORLENZA VINCENT A Chairman, CEO and President
Sold, plan not stated
$8.01M 28,514 at 280.96
12.0%
27 Jan 2020
FORLENZA VINCENT A Chairman, CEO and President
Sold, plan not stated
$7.16M 25,546 at 280.09
10.9%
24 Jan 2020
FORLENZA VINCENT A Chairman, CEO and President
Sold, plan not stated
$2.01M 7,177 at 280.13
3.3%
23 Jan 2020
FORLENZA VINCENT A Chairman, CEO and President
Sold, plan not stated
$1.76M 6,284 at 280.06
2.9%
10 Jan 2020
FORLENZA VINCENT A Chairman, CEO and President
Sold, plan not stated
$5.41M 19,675 at 275.15
8.6%
8 Jan 2020
FORLENZA VINCENT A Chairman, CEO and President
Sold, plan not stated
$3.81M 13,860 at 275.19
6.2%
2 Jan 2020
FORLENZA VINCENT A Chairman, CEO and President
Sold, plan not stated
$9.05M 33,365 at 271.28
13.8%
16 Dec 2019
Mas Ribo Alberto EVP and Pres, Life Sciences
Sold, plan not stated
$3.20M 11,860 at 269.51
54.7%
Sold half or more
16 Dec 2019
Polen Thomas E Jr Executive Vice President
Sold, plan not stated 2×
$1.72M 6,386 at 269.63
27.2%
13 Dec 2019
Spoerel Thomas J VP Controller & Chief Acct Off
Sold, plan not stated
$135.58K 506 at 267.95
32.8%
12 Dec 2019
FORLENZA VINCENT A Chairman, CEO and President
Sold, plan not stated
$3.09M 11,626 at 265.57
5.3%
12 Dec 2019
Kaltenbach Patrick EVP & Pres Life Sciences
Sold, plan not stated
$89.23K 339 at 263.23
2.2%
6 Dec 2019
Kaltenbach Patrick EVP & Pres Life Sciences
Sold, plan not stated
$81.59K 312 at 261.51
2.0%
Showing 51–100 of 159. ← Newer Page 2 of 4 Older →